Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G O Littlejohn

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Lupus|January 1, 1997
Methotrexate use in systemic lupus erythematosusY Kipen, G O Littlejohn, E F Morand
Postgraduate Medical Journal|February 1, 1988
The diagnosis and classification of scleroderma (systemic sclerosis)A J Barnett, M Miller, G O Littlejohn
Clinical and Experimental Neurology|January 1, 1987
Neurogenic flare responses in chronic rheumatic pain syndromesR D Helme, G O Littlejohn, C Weinstein
The Journal of Rheumatology|October 1, 1987
Increased neurogenic inflammation in fibrositis syndromeG O Littlejohn, C Weinstein, R D Helme
The Journal of Rheumatology|October 1, 1991
Epidemiology of soft tissue rheumatism: the influence of the lawP A Reilly, R Travers, G O LittleJohn
Arthritis and Rheumatism|August 1, 1980
Reiter's syndrome after Campylobacter jejuni enteritisF Y Leung, G O Littlejohn, C Bombardier
Australian and New Zealand Journal of Medicine|April 17, 1998
Pregnancy outcome in systemic lupus erythematosus (SLE): a review of 54 casesK R Johns, E F Morand, G O Littlejohn
The Journal of Rheumatology|May 1, 1992
Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practiceE F Morand, P I McCloud, G O Littlejohn
Annals of the Rheumatic Diseases|October 1, 1994
Combination therapy with methotrexate and sulphasalazine in rheumatoid arthritis--tolerance of therapyR S Axtens, E F Morand, G O Littlejohn
Annals of the Rheumatic Diseases|February 1, 1981
Central retinal vein occlusion and scleroderma: implications for sclerodermatous vascular diseaseG O Littlejohn, M B Urowitz, C J Pavlin
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Lupus|January 1, 1997
Methotrexate use in systemic lupus erythematosusY Kipen, G O Littlejohn, E F Morand
Postgraduate Medical Journal|February 1, 1988
The diagnosis and classification of scleroderma (systemic sclerosis)A J Barnett, M Miller, G O Littlejohn
Clinical and Experimental Neurology|January 1, 1987
Neurogenic flare responses in chronic rheumatic pain syndromesR D Helme, G O Littlejohn, C Weinstein
The Journal of Rheumatology|October 1, 1987
Increased neurogenic inflammation in fibrositis syndromeG O Littlejohn, C Weinstein, R D Helme
The Journal of Rheumatology|October 1, 1991
Epidemiology of soft tissue rheumatism: the influence of the lawP A Reilly, R Travers, G O LittleJohn
Arthritis and Rheumatism|August 1, 1980
Reiter's syndrome after Campylobacter jejuni enteritisF Y Leung, G O Littlejohn, C Bombardier
Australian and New Zealand Journal of Medicine|April 17, 1998
Pregnancy outcome in systemic lupus erythematosus (SLE): a review of 54 casesK R Johns, E F Morand, G O Littlejohn
The Journal of Rheumatology|May 1, 1992
Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practiceE F Morand, P I McCloud, G O Littlejohn
Annals of the Rheumatic Diseases|October 1, 1994
Combination therapy with methotrexate and sulphasalazine in rheumatoid arthritis--tolerance of therapyR S Axtens, E F Morand, G O Littlejohn
Annals of the Rheumatic Diseases|February 1, 1981
Central retinal vein occlusion and scleroderma: implications for sclerodermatous vascular diseaseG O Littlejohn, M B Urowitz, C J Pavlin
Pageof 9